Live Breaking News & Updates on Coherus biosciences

Stay informed with the latest breaking news from Coherus biosciences on our comprehensive webpage. Get up-to-the-minute updates on local events, politics, business, entertainment, and more. Our dedicated team of journalists delivers timely and reliable news, ensuring you're always in the know. Discover firsthand accounts, expert analysis, and exclusive interviews, all in one convenient destination. Don't miss a beat — visit our webpage for real-time breaking news in Coherus biosciences and stay connected to the pulse of your community

Coherus Announces Presentation at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting

REDWOOD CITY, Calif., April 24, 2024 -- Coherus BioSciences, Inc. today announced the first presentation of clinical data for CHS-114, a highly selective cytolytic anti-CCR8 antibody, at the...

Mccormick-place , Illinois , United-states , Chicago , Coherus-biosciences , Jodi-sievers , Jami-taylor , Amgen-inc , Abbvie-inc , Exchange-commission , Coherus-biosciences-inc , Corporate-communications

Coherus Announces Presentation at the 2024 American Society

REDWOOD CITY, Calif., April 24, 2024 (GLOBE NEWSWIRE) -- Coherus BioSciences, Inc. (Coherus, Nasdaq: CHRS) today announced the first presentation of...

Mccormick-place , Illinois , United-states , Chicago , Jami-taylor , Jodi-sievers , Coherus-biosciences , Corporate-communications , Exchange-commission-on , Exchange-commission , Abbvie-inc , Nasdaq

PharmaEssentia Appoints Robert Geller, M.D. as Head of Medical and Shawn Gibbs, J.D. as Head of Legal

PharmaEssentia Appoints Robert Geller, M.D. as Head of Medical and Shawn Gibbs, J.D. as Head of Legal
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United-states , Taipei , T-ai-pei , Taiwan , Japan , China , American , Taiwanese , Robert-geller , Ko-chung-lin , Ching-leou-teng , Albert-qin

PharmaEssentia Appoints Robert Geller, M.D. as Head of Medical and Shawn Gibbs, J.D. as Head of Legal

PharmaEssentia Appoints Robert Geller, M.D. as Head of Medical and Shawn Gibbs, J.D. as Head of Legal
eagletribune.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from eagletribune.com Daily Mail and Mail on Sunday newspapers.

China , Massachusetts-institute-of-technology , Massachusetts , United-states , Taiwan , Burlington , Japan , Taipei , T-ai-pei , American , Taiwanese , Albert-qin

Amjevita leads Humira biosimilars in clinician comfort as rheumatologists remain wary

Amjevita leads Humira biosimilars in clinician comfort as rheumatologists remain wary
healio.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from healio.com Daily Mail and Mail on Sunday newspapers.

New-york , United-states , Samsung-bioepis , Byrob-volansky , Shenaz-bagha , Coherus-biosciences , Amgen , Boehringer-ingelheim , Weill-cornell-medical-college , Spherix-global , Amelia-bond , Global-insights

Peregrine Capital Management LLC Sells 288,606 Shares of Coherus BioSciences, Inc. (NASDAQ:CHRS)

Peregrine Capital Management LLC trimmed its stake in shares of Coherus BioSciences, Inc. (NASDAQ:CHRS – Free Report) by 20.9% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 1,089,961 shares of the biotechnology company’s stock after selling 288,606 shares […]

United-states , China , Ohio , Coherus-biosciences , Robertw-baird , China-universal-asset-management-co , Sg-americas-securities , Coherus-biosciences-inc , Steelpeak-wealth , Peregrine-capital-management , International-assets-investment-management , Exchange-commission

Coherus BioSciences, Inc. (NASDAQ:CHRS) Shares Sold by Peregrine Capital Management LLC

Peregrine Capital Management LLC lowered its position in shares of Coherus BioSciences, Inc. (NASDAQ:CHRS – Free Report) by 20.9% in the fourth quarter, according to the company in its most recent filing with the SEC. The firm owned 1,089,961 shares of the biotechnology company’s stock after selling 288,606 shares during the quarter. Peregrine Capital Management […]

United-states , Robertw-baird , Coherus-biosciences , Hermes-inc , Princeton-global-asset-management , Coherus-biosciences-inc , Eagle-bay-advisors , Peregrine-capital-management , Dorsey-whitney-trust , Nasdaq , Free-report , Capital-management

Biosimilars in Retina Space Expected to Grow in 2024, Coming Years

In a review, investigators focused on ranibizumab (Lucentis; Genentech), aflibercept (Eylea; Regeneron), and bevacizumab (Avastin; Genentech) as growth opportunities in the biosimilar space.

China , United-states , P-biocon-biologics , Samsung-bioepis , Fran-gregory , Coherus-biosciences , Genentech , Therapies-at-cardinal-health , Momenta-pharmaceuticals , Amgen , Pivotal-year , Pharmacy-times

Carr Financial Group Corp Makes New Investment in Coherus BioSciences, Inc. (NASDAQ:CHRS)

Carr Financial Group Corp purchased a new position in Coherus BioSciences, Inc. (NASDAQ:CHRS – Free Report) during the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund purchased 35,195 shares of the biotechnology company’s stock, valued at approximately $117,000. A number of other hedge funds […]

United-states , Switzerland , Swiss , Robertw-baird , Coherus-biosciences , Nasdaq , Brandywine-global-investment-management , Exchange-commission , Barclays-plc , Coherus-biosciences-inc , Swiss-national-bank , Carr-financial-group-corp

Coherus Presents Preclinical Data for CHS-1000, a Novel Anti-ILT4 Antibody, at the 2024 AACR Annual Meeting

– In preclinical studies, CHS-1000 shows a high affinity for human ILT4, reverses ILT4-mediated immunosuppressive functions, leading to activation of immune cells and increased cytokine secretion...

San-diego , California , United-states , Jami-taylor , Coherus-biosciences , Jodi-sievers , Narendiran-rajasekaran , Theresa-lavallee , Exchange-commission-on , Nasdaq , Exchange-commission , Coherus-biosciences-inc